Seizures, encephalopathy |
EEG |
Epileptiform abnormality, diffuse slowing |
Anticonvulsants |
Stroke-like episodes |
MRI brain |
High-signal T2 abnormality not conforming to vascular territories, posterior-predominant |
L-arginine a possible therapy |
Sensory neuropathy |
Nerve conduction studies |
Axonal sensory or sensorimotor neuropathy |
Symptomatic therapy |
Myopathy |
CK |
Normal or slightly elevated. May be very high in CoQ10 deficiency |
|
EMG |
Myopathic changes or normal |
|
Respiratory failure |
PFTs, sleep studies |
Decreased FVC. Apnoeic episodes during sleep |
CPAP or BiPAP |
Cardiac |
Electrocardiogram |
Conduction abnormalities |
Antiarrhythmics, pacemaker |
|
Echocardiogram |
Cardiomyopathy |
ACE inhibitors |
Endocrinopathy |
Fasting glucose, glucose tolerance test, HgBA1c, TSH, calcium, PTH, cortisol, synacthen test |
Abnormalities consistent with type 2 diabetes mellitus, and/or hypothyroidism, and/or hypoparathyroidism, and/or adrenal failure |
Oral antihyperglycaemic agents and/or insulin; L-thyroxine; hydrocortisone |
Cognitive dysfunction |
Mental status testing |
May indicate cognitive impairment |
|
Hearing loss |
Audiography |
Sensorineural-type hearing loss |
Auditory aids, cochlear implantation |
Ocular symptoms/signs |
Ophthalmology referral |
Oculomotor abnormalities, optic atrophy, pigmentary retinopathy |
Corrective lenses, surgery for strabismus or ptosis |
Dysphagia |
Swallowing studies (video fluoroscopy or manometry) |
Cricopharyngeal achalasia or oesophagealdysmotility |
Dietary modification |
Other general tests |
Serum lactate |
Normal, or elevated |
|
|
CSF lactate |
Normal, or elevated |
|
|
CSF analysis |
Normal, or elevated protein |
|
|
CT brain |
Normal, or basal ganglia calcifications ± atrophy |
|
|
MRI brain |
Basal ganglia signal abnormalities, non-specific white matter abnormalities, stroke-like lesions, cerebellar or brain-stem atrophy, or normal. MR spectroscopy may demonstrate elevated lactate |
|